Optive Eye Drops

Optive is a prominent line of lubricating eye drops designed to provide relief for dry and irritated eyes. The brand was originally developed by Allergan, a pharmaceutical company that pioneered various treatments in the ophthalmology sector. The product formulation is known for its dual-action approach, lubricating the ocular surface while also providing osmoprotection to the cells of the cornea.

Over the years, the ownership of the brand has transitioned through major corporate mergers. Allergan was acquired by the global pharmaceutical giant AbbVie in 2020. As of 2024 and moving forward, Optive remains a key part of AbbVie's eye care portfolio, which is managed under the Allergan Aesthetics and Eye Care divisions. Manufacturing occurs primarily at high-standard pharmaceutical facilities in the United States and Ireland to supply global markets.